Evaluation of (131)I-pentamidine for scintigraphy of experimentally Leishmania tropica-infected hamsters

J Drug Target. 2014 Jun;22(5):416-20. doi: 10.3109/1061186X.2013.878943. Epub 2014 Jan 9.

Abstract

We aimed to assess the ability of (131)I-Pentamidine scintigraphy to detect the lesions of Leishmania tropica infection. An experimental model of cutaneous leishmaniasis was developed. The presence of cutaneous leishmaniasis was confirmed. Pentamidine was radioiodinated with (131)I. The radiolabeled pentamidine was validated by the requisite quality control tests to check its radiolabeling efficiency, in vitro stability. (131)I-Pentamidine (activity: 18.5 MBq/100 µl) was injected intracardiacally into infected hamsters. Static whole body images of the hamsters were acquired under the gamma camera at 5 and 30 min, 2, 6 and 24 h following the administration. On the scintigrams, anatomically adjusted regions of interest (ROIs) were drawn over the right feet (target) and left feet (not-target) and various organs. Accumulation of (131)I-Pentamidine at sites of infection is expressed as the target to non-target (T/NT) ratio. The results T/NT ratio decreased with time. In concluding the (131)I-Pentamidine has poor sensitivity in detection of L. tropica infection.

Keywords: 131I-Pentamidine scintigraphy; Amastigote; Leishmania tropica; Leishmaniasis hamster; promastigote.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Iodine Radioisotopes
  • Leishmania tropica / drug effects
  • Leishmania tropica / isolation & purification*
  • Leishmaniasis, Cutaneous / diagnostic imaging*
  • Leishmaniasis, Cutaneous / parasitology
  • Male
  • Mesocricetus
  • Pentamidine* / chemistry
  • Pentamidine* / pharmacokinetics
  • Radionuclide Imaging
  • Tissue Distribution
  • Trypanocidal Agents* / chemistry
  • Trypanocidal Agents* / pharmacokinetics
  • Whole Body Imaging*

Substances

  • Iodine Radioisotopes
  • Trypanocidal Agents
  • Pentamidine